Acasti Pharma Quick Ratio 2014-2024 | GRCE

Historical quick ratio values for Acasti Pharma (GRCE) over the last 10 years.
Acasti Pharma Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-06-30 $0.00B $0.00B 0.00
2024-03-31 $0.00B $0.00B 0.00
2023-12-31 $0.00B $0.00B 0.00
2023-09-30 $0.00B $0.00B 0.00
2023-06-30 $0.00B $0.00B 0.00
2023-03-31 $0.00B $0.00B 0.00
2022-12-31 $0.00B $0.00B 0.00
2022-09-30 $0.00B $0.00B 0.00
2022-06-30 $0.00B $0.00B 0.00
2022-03-31 $0.00B $0.00B 0.00
2021-12-31 $0.00B $0.00B 0.00
2021-09-30 $0.00B $0.00B 0.00
2021-06-30 $0.00B $0.00B 0.00
2021-03-31 $0.00B $0.00B 0.00
2020-12-31 $0.03B $0.00B 13.43
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.01B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.01B 0.00
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.01B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-02-28 $0.00B $0.00B 0.00
2016-11-30 $0.00B $0.00B 0.00
2016-08-31 $0.00B $0.00B 0.00
2016-05-31 $0.00B $0.00B 0.00
2016-03-31 $0.00B $0.00B 0.00
2016-02-29 $0.00B 0.00
2015-12-31 $0.01B $0.00B 9.07
2015-09-30 $0.01B $0.00B 13.47
2015-06-30 $0.01B $0.00B 8.27
2015-03-31 $0.02B $0.00B 12.10
2014-12-31 $0.02B $0.00B 10.47
2014-09-30 $0.02B $0.00B 9.31
2014-06-30 $0.02B $0.00B 12.84
2014-03-31 $0.02B $0.00B 21.84
2014-02-28 $0.00B 0.00
2013-12-31 $0.01B $0.01B 0.99
2013-09-30 $0.01B $0.00B 1.29
2013-06-30 $0.01B $0.00B 1.65
2013-03-31 $0.01B $0.00B 2.31
Sector Industry Market Cap Revenue
Medical MED-GENERIC DRG $0.033B $0.000B
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Merck (MKKGY) Germany $21.306B 23.25
New York Community Bancorp (FLG) United States $4.269B 0.00